Pacific Biosciences of California, Inc. Common Stock (NASDAQ: PACB) last traded at $1.35, up 9.76% on the session. The quote above updates while this page is open; the figures below are drawn from Pacific Biosciences of California, Inc. Common Stock’s own filings and are restated only when a new one is published.
Pacific Biosciences of California, Inc. Common Stock trades on NASDAQ under the ticker PACB. Its market capitalisation is $419.62 million.
Valuation measures for Pacific Biosciences of California, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $419.62M |
|---|---|
| Enterprise value | $1.14B |
| Price / sales | 2.63 |
| Beta | 2.45 |
Trailing-twelve-month figures tagged in Pacific Biosciences of California, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $159.27M |
|---|---|
| Net income (TTM) | -$131.39M |
| EPS (TTM) | -$0.410 |
| Gross margin | 36.38% |
| Operating margin | -83.53% |
| Cash | $61.00M |
Range and volume for PACB over the past 52 weeks.
| 52-week high | $2.73 |
|---|---|
| 52-week low | $1.07 |
| Volume | 7.07M |
| Average volume | 6.54M |
| Previous close | $1.23 |
Dividend history for Pacific Biosciences of California, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.